📰 Danilo Lembo News
Danilo Lembo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Danilo Lembo. Real-time updates on events, politics, business and more.
June 29, 2022
Interim data presented at the European Academy of Neurology 2022 shows that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more over the six-month period from the start of treatment.
June 26, 2022
Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab) - read this article along with other careers information, tips and advice on BioSpace
June 24, 2022
Interim data presented at the European Academy of Neurology 2022 shows that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more over the six-month period from the start
June 24, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
February 16, 2022
Teva Pharmaceuticals Europe BV has confirmed that the SmPC for COPAXONE® (Glatiramer Acetate (GA) injection) 20mg/mL and 40mg/mL, indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in Europe, has been updated.
February 10, 2022
Change to COPAXONE(Glatiramer Acetate (GA)) Summary of Product Characteristics (SmPC) in breastfeeding is relevant for the Multiple Sclerosis ("MS") community and provides information for neurologists
October 13, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.